If you arent familiar with Victoza then I would recommend reading this article first, which goes into detail about the basics of GLP-1 agonists and how they work for weight loss
The magnitude of blood pressure change depends on your starting blood pressure, baseline weight, kidney function, and whether you take other cardiovascular medications
The benefits of expanded access to these drugs extend beyond mortality reduction, as it could also alleviate obesity-related comorbidities, including cardiovascular disease, diabetes, and even infections such as COVID-19
Was this a case of bad due diligence or a calculated decision to deprioritise a maturing market while pivoting to next-gen GLP-1 assets in the pipeline
As infectious diseases continue to be a global health concern, natural compounds with antimicrobial potential are being extensively studied for their efficacy and safety (Chang et al